BackGenerate Biomedicines Overview
Generate Biomedicines, Inc.

Generate Biomedicines Target Price

Analysts' average 12-month price target for Generate Biomedicines is $30.

Get informed when a big investor buys or sells

+ Follow

Share Price

$15.99

Average Target Price

$30.0087.6% upside

1 analysts in the last 4 months

High: $30 | Low: $30

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-28H.C. Wainwright$3087.6% upsideOpen
2026-05-14Morgan StanleySean Laaman$2237.6% upsideOpen
2026-05-08H.C. WainwrightMitchell Kapoor$2556.3% upsideOpen

Generate Biomedicines (GENB) FAQ

The latest target price for GENB is $30. Investors often review this figure alongside Generate Biomedicines's historical trend and sector peers before judging valuation or financial health.

Generate Biomedicines trades near $15.99 while the consensus target sits at $30 (87.6% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting GENB's target price ($30), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.